1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Newly Diagnosed Mixed Phenotype Acute Leukemia: new trials by email Literature Review of Newly Diagnosed Mixed Phenotype Acute Leukemia trials Research Report on Newly Diagnosed Mixed Phenotype Acute Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia BCL-2 indibitor, Azacitidine (AZA), Blinatumomab - Newly Diagnosed Mixed Phenotype Acute Leukemia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 52 | 2026-05-01 | 2026-05-07 |
Azacitidine (1) · blinatumomab (1)
The First Affiliated Hospital of Soochow University (1)
China (1)
Suning Chen (1)